Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

August 6, 2020

Appendix cancer survival in young patients varies by race: study

The first study of appendiceal cancer patterns and survival by race/ethnicity among patients younger than 50 in the U.S. showed survival disparities.

By Leigh MacMillan
August 6, 2020

Davis named senior medical director for VICC Cancer Care Network and Strategy

Nancy Davis, MD, has been named senior medical director for VICC Cancer Care Network and Strategy, a new leadership position at Vanderbilt-Ingram Cancer Center responsible for expanding cancer clinics within and beyond the Middle Tennessee catchment area.

By Tom Wilemon
August 6, 2020

Goff named executive medical director for the VICC Cancer Patient Care Center

Laura Goff, MD, MSCI, associate professor of Medicine, has been named the executive medical director for the Vanderbilt-Ingram Cancer Center (VICC) Cancer Patient Care Center.

By Tom Wilemon
July 28, 2020

Post-transplant complication

Vanderbilt researchers conducted the largest analysis to date of a heart complication in children following stem cell transplant. The findings may help guide screening practices to improve outcomes.

By Leigh MacMillan
July 23, 2020

Cellular antiviral defenses

A cellular RNA quality control mechanism was known to restrict replication of RNA viruses. Vanderbilt researchers have discovered it is also antiviral against DNA viruses.

By Leigh MacMillan
Ann Richmond, PhD, is stepping down from her role as associate director for Research Education at Vanderbilt-Ingram Cancer Center.
July 16, 2020

Richmond steps down as associate director for Research Education for VICC

After serving 16 years as associate director for Research Education at Vanderbilt-Ingram Cancer Center (VICC), Ann Richmond, PhD, Ingram Professor of Cancer Research, is stepping down from the leadership post.

By Tom Wilemon
July 15, 2020

Two brushes with death. Two life-saving Vanderbilt physicians. Then, two children.

"Vanderbilt will always be a place that we hold dear for everything they have done for us,” says Mary Beth Ballard Murray.
By Matt Batcheldor
July 2, 2020

Friedman named associate director for Community Science and Health Outcomes at Vanderbilt-Ingram Cancer Center

Debra Friedman, MD, MS, E. Bronson Ingram Chair of Pediatric Oncology, is expanding her leadership role in improving cancer outcomes both within and beyond the Vanderbilt-Ingram Cancer Center (VICC) catchment area. She has been named associate director of Community Science and Health Outcomes.
By Tom Wilemon
July 2, 2020

Fe y Salud webinar addresses disproportionate effects of COVID-19 on Latino community

The Latino community is affected disproportionately by COVID-19. News outlets report leaders and lawmakers calling its impact “catastrophic.” In the state of Tennessee, one-third of residents who test positive for the coronavirus are Hispanic, even though only 5.6 percent of the population is Hispanic.
By Matt Schorr
June 18, 2020

Probing DNA damage repair

After discovering a new mechanism for DNA damage repair last year, Vanderbilt biochemists now provide direct evidence for how it works.
By Leigh MacMillan
June 18, 2020

Cortez named to VICC research leadership role

David Cortez, PhD, has been named associate director for Basic Science Research at Vanderbilt-Ingram Cancer Center (VICC).
By Tom Wilemon
June 2, 2020

First quarter DAISY Awards honor three extraordinary nurses

DAISY Awards are given to great nurses all over the United States and in many other countries. This is Vanderbilt's latest group.
By Matt Batcheldor
May 26, 2020

ASCO press program highlights COVID-19 outcomes in lung cancer patients

People with thoracic cancers sickened by COVID-19 were especially vulnerable to deaths with a 35% mortality rate, according to early results from TERAVOLT, a global consortium that tracks outcomes among this vulnerable patient population.
By Tom Wilemon
1 … 15 16 17 18 19 … 58